Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk

Introduction: The full range of cutaneous comorbidities associated with keratinocyte skin cancers remains to be elucidated. Objectives: We aimed to examine other skin diseases in patients with keratinocyte cancer (KC) and to reveal potential associations between them. Methods: Included in the s...

Full description

Saved in:
Bibliographic Details
Main Authors: Asli Aksu, Aysenur Demir, Hatice Gunay, Pinar Ozdemir Cetinkaya, Birgul Ozkesici Kurt, Hazel Ezgi Kaya, Ilknur Altunay, Deniz Altınel
Format: Article
Language:English
Published: Mattioli1885 2025-07-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/5264
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331076000907264
author Asli Aksu
Aysenur Demir
Hatice Gunay
Pinar Ozdemir Cetinkaya
Birgul Ozkesici Kurt
Hazel Ezgi Kaya
Ilknur Altunay
Deniz Altınel
author_facet Asli Aksu
Aysenur Demir
Hatice Gunay
Pinar Ozdemir Cetinkaya
Birgul Ozkesici Kurt
Hazel Ezgi Kaya
Ilknur Altunay
Deniz Altınel
author_sort Asli Aksu
collection DOAJ
description Introduction: The full range of cutaneous comorbidities associated with keratinocyte skin cancers remains to be elucidated. Objectives: We aimed to examine other skin diseases in patients with keratinocyte cancer (KC) and to reveal potential associations between them. Methods: Included in the study were 200 patients with KC and 200 disease-free controls. To identify any additional concomitant dermatological conditions, all study groups underwent examination by 2 dermatologists. Results: In patients with KC, 87.5% were diagnosed with basal cell carcinoma and 13.5% were diagnosed with squamous cell carcinoma. There was no statistically significant difference between the two groups regarding sunscreen use habits (P =0.284). Patients with KC exhibited a significantly elevated odds ratio for the presence of rosacea (OR 5.13, 95% CI 3.2-8.3, P=0.000) and especially erythematotelangiectatic rosacea (ETR) subtype (OR 5.03, 95% CI 3.1-8.2, P=0.000). An ROC curve analysis was conducted to assess the efficacy of rosacea in differentiating between the control group and patients with KC. The sensitivity, specificity, negative predictive value and positive predictive value for rosacea were 45.5%, 86%, 61.2% and 76.5%, respectively (AUC 0.658, 95% CI 0.604-0.711, P=0.000), while for ETR it was 44%, 86.5%, 60.7% and 76.5%, respectively (AUC 0.653, 95% CI 0.599-0.706, P=0.000). The presence of rosacea demonstrated a significant efficacy in differentiating patients with KC from the control group in all localizations (P< 0.05). Conclusion: The risk of rosacea in patients with KC, particularly those with the ETR subtype, was found to be significantly elevated, irrespective of age, gender, and localization.
format Article
id doaj-art-33535dfdbf584f03bfa17e031e73ce4d
institution Kabale University
issn 2160-9381
language English
publishDate 2025-07-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-33535dfdbf584f03bfa17e031e73ce4d2025-08-20T03:46:45ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-07-0115310.5826/dpc.1503a5264Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma RiskAsli Aksu0https://orcid.org/0000-0003-3979-7486Aysenur Demir1Hatice Gunay2Pinar Ozdemir Cetinkaya3Birgul Ozkesici Kurt4Hazel Ezgi Kaya5Ilknur Altunay6Deniz Altınel7"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Dermatology"}"University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Pathology"} Introduction: The full range of cutaneous comorbidities associated with keratinocyte skin cancers remains to be elucidated. Objectives: We aimed to examine other skin diseases in patients with keratinocyte cancer (KC) and to reveal potential associations between them. Methods: Included in the study were 200 patients with KC and 200 disease-free controls. To identify any additional concomitant dermatological conditions, all study groups underwent examination by 2 dermatologists. Results: In patients with KC, 87.5% were diagnosed with basal cell carcinoma and 13.5% were diagnosed with squamous cell carcinoma. There was no statistically significant difference between the two groups regarding sunscreen use habits (P =0.284). Patients with KC exhibited a significantly elevated odds ratio for the presence of rosacea (OR 5.13, 95% CI 3.2-8.3, P=0.000) and especially erythematotelangiectatic rosacea (ETR) subtype (OR 5.03, 95% CI 3.1-8.2, P=0.000). An ROC curve analysis was conducted to assess the efficacy of rosacea in differentiating between the control group and patients with KC. The sensitivity, specificity, negative predictive value and positive predictive value for rosacea were 45.5%, 86%, 61.2% and 76.5%, respectively (AUC 0.658, 95% CI 0.604-0.711, P=0.000), while for ETR it was 44%, 86.5%, 60.7% and 76.5%, respectively (AUC 0.653, 95% CI 0.599-0.706, P=0.000). The presence of rosacea demonstrated a significant efficacy in differentiating patients with KC from the control group in all localizations (P< 0.05). Conclusion: The risk of rosacea in patients with KC, particularly those with the ETR subtype, was found to be significantly elevated, irrespective of age, gender, and localization. https://dpcj.org/index.php/dpc/article/view/5264Rosacea And Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Risk, Keratinocyte Carcinoma, Dermatological Diseases
spellingShingle Asli Aksu
Aysenur Demir
Hatice Gunay
Pinar Ozdemir Cetinkaya
Birgul Ozkesici Kurt
Hazel Ezgi Kaya
Ilknur Altunay
Deniz Altınel
Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
Dermatology Practical & Conceptual
Rosacea And Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Risk, Keratinocyte Carcinoma, Dermatological Diseases
title Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
title_full Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
title_fullStr Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
title_full_unstemmed Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
title_short Impact of Rosacea on Keratinocyte Skin Cancers: A Prospective Case-Control Study of Basal and Squamous Cell Carcinoma Risk
title_sort impact of rosacea on keratinocyte skin cancers a prospective case control study of basal and squamous cell carcinoma risk
topic Rosacea And Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Risk, Keratinocyte Carcinoma, Dermatological Diseases
url https://dpcj.org/index.php/dpc/article/view/5264
work_keys_str_mv AT asliaksu impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT aysenurdemir impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT haticegunay impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT pinarozdemircetinkaya impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT birgulozkesicikurt impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT hazelezgikaya impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT ilknuraltunay impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk
AT denizaltınel impactofrosaceaonkeratinocyteskincancersaprospectivecasecontrolstudyofbasalandsquamouscellcarcinomarisk